Characteristics of Study Population
| Parameter | Value |
| No. of patients | 13 |
| Sex | |
| Male | 6 |
| Female | 7 |
| Age (y) | 56.9 (range, 43.3–60.9) |
| Cause of kidney transplantation | |
| Autosomal dominant polycystic kidney disease | 4/13 |
| Glomerulonephritis | 2/13 |
| Cystic kidney degeneration | 1/13 |
| Diabetic nephropathy | 1/13 |
| IgA nephropathy | 1/13 |
| Acute kidney injury | 1/13 |
| Congenital kidney hypoplasia | 1/13 |
| Nephrosclerosis | 1/13 |
| Refluxnephropathy with recurrent UTI | 1/13 |
| Transplantation details | |
| Living donor transplantation | 7/13 |
| Second transplantation | 3/13 |
| Time after transplantation (y) | 6.2 (3.3–9.5) |
| Laboratory values during infection | |
| Serum leukocytes (103/μL) | 8.4 (5.9–11.6) |
| Serum CRP (mg/L) | 48.6 (5.2–116.9) |
| Serum creatinine (μmol/L) | 253 (187–359) |
| eGFR (mL/min/1.73m2) | 22.0 (14.5–28.0) |
| Urine leukocytes (cells/μL) | 29 (8–864) |
| Laboratory values after therapy | |
| Serum leukocytes (103/μL) | 8.7 (4.7–10.9) |
| Serum CRP (mg/L) | 5.7 (1.6–39.5) |
| Serum creatinine (μmol/L) | 204 (160–335) |
| eGFR (mL/min/1.73m2) | 23.0 (15.0–35.0) |
| Urine leukocytes (cells/μL) | 9 (1–540) |
Values are median with IQR in parentheses.